Company profile: Phase Forward
1.1 - Company Overview
Company description
- Provider of integrated data collection and data management solutions for clinical trials and drug safety, offering technology and global services that help life sciences companies automate and integrate clinical development processes from study initiation to FDA submission.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Phase Forward
Tx3
HQ: United States
Website
- Description: Provider of automated quality and compliance SaaS solutions for software testing within Life Science companies, enabling agile adoption and efficient adherence to regulatory requirements such as 21 CFR Part 11. Offerings include Tricentis Tosca, qTest, NeoLoad, LiveCompare, and Data Integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tx3 company profile →
Genedata
HQ: Switzerland
Website
- Description: Provider of bioinformatics software and scientific consulting services for drug discovery and life sciences, delivering platforms for biopharma R&D digitalization, screening data analysis, NGS-based cell line development and biosafety, biologics bioprocess design, mass spectrometry–based biotherapeutic characterization and quality monitoring, and multi-omics, biomarker, and clinical data integration for precision medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genedata company profile →
Marken
HQ: United States
Website
- Description: Provider of patient-centric clinical trial logistics for the pharmaceutical and life sciences industries, including clinical trial sample delivery, chain of custody shipping, global control center monitoring, real-time clinical shipment tracking, vaccine trial storage, and a home healthcare management system; maintains a leading position in Direct to Patient services and biological sample shipments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marken company profile →
Benchling
HQ: United States
Website
- Description: Provider of a cloud-based platform for biology researchers and R&D organizations, including the Benchling R&D Cloud to centralize and standardize scientific data, enable collaboration, and provide insights; Benchling Bioresearch to design and manage experiments, biomolecules, workflows, and results; Benchling Notebook; plus CRISPR guide RNA design and sequence alignment tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Benchling company profile →
Emerald BioSystems
HQ: United States
Website
- Description: Provider of sophisticated laboratory automation, software tools, and consumable products for gene-to-protein crystal structure research, offering integrated solutions for biotechnology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emerald BioSystems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Phase Forward
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Phase Forward
2.2 - Growth funds investing in similar companies to Phase Forward
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Phase Forward
4.2 - Public trading comparable groups for Phase Forward
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →